Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS
Authors:
- Seung H. KimSKSeung H. Kim
- 1 June 2007
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 205 (2) , 336-346
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS modelProceedings of the National Academy of Sciences, 2006
- Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinaseOncogene, 2005
- Role of GSK‐3β activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 geneEuropean Journal of Neuroscience, 2005
- Glycogen synthase kinase 3: a drug target for CNS therapiesJournal of Neurochemistry, 2004
- Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein inductionJournal of Neurochemistry, 2004
- NGF activates the phosphorylation of MAP1B by GSK3β through the TrkA receptor and not the p75NTRreceptorJournal of Neurochemistry, 2003
- Aggregate Formation in Cu,Zn Superoxide Dismutase-related ProteinsJournal of Biological Chemistry, 2003
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingProgress in Neurobiology, 2001
- Mutant Mice, Cu,Zn Superoxide Dismutase, and Motor Neuron DegenerationScience, 1994
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993